These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 25006102)

  • 1. [Recurrent hyperperfusion after revascularization surgery for adult moyamoya disease: a case report].
    Hayashi T; Kashiwazaki D; Akioka N; Kuwayama N; Kuroda S
    No Shinkei Geka; 2014 Jul; 42(7):621-7. PubMed ID: 25006102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability.
    Fujimura M; Shimizu H; Mugikura S; Tominaga T
    Surg Neurol; 2009 Feb; 71(2):223-7; discussion 227. PubMed ID: 18291489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient crossed cerebellar diaschisis due to cerebral hyperperfusion following surgical revascularization for moyamoya disease: case report.
    Hokari M; Kuroda S; Simoda Y; Uchino H; Hirata K; Shiga T; Nakayama N; Houkin K; Tamaki N
    Neurol Med Chir (Tokyo); 2012; 52(5):350-3. PubMed ID: 22688075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
    Hayashi T; Shirane R; Fujimura M; Tominaga T
    J Neurosurg Pediatr; 2010 Jul; 6(1):73-81. PubMed ID: 20593991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease.
    Fujimura M; Kaneta T; Mugikura S; Shimizu H; Tominaga T
    Surg Neurol; 2007 Mar; 67(3):273-82. PubMed ID: 17320638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local Vasogenic Edema without Cerebral Hyperperfusion after Direct Revascularization Surgery for Moyamoya Disease.
    Sakata H; Fujimura M; Mugikura S; Sato K; Tominaga T
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):e179-84. PubMed ID: 25957910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of early postoperative cerebral blood flow contributes to the prediction and diagnosis of cerebral hyperperfusion syndrome after revascularization surgery for moyamoya disease.
    Fujimura M; Niizuma K; Endo H; Sato K; Inoue T; Shimizu H; Tominaga T
    Neurol Res; 2015 Feb; 37(2):131-8. PubMed ID: 25082550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphasic Development of Focal Cerebral Hyperperfusion After Revascularization Surgery for Adult Moyamoya Disease Associated With Autosomal Dominant Polycystic Kidney Disease.
    Tashiro R; Fujimura M; Endo H; Endo T; Niizuma K; Tominaga T
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3256-3260. PubMed ID: 30093201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in a child with moyamoya disease.
    Fujimura M; Kaneta T; Shimizu H; Tominaga T
    Childs Nerv Syst; 2007 Oct; 23(10):1195-8. PubMed ID: 17486352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic value of perfusion-weighted MRI for evaluating postoperative alteration of cerebral hemodynamics following STA-MCA anastomosis in patients with moyamoya disease].
    Fujimura M; Mugikura S; Shimizu H; Tominaga T
    No Shinkei Geka; 2006 Aug; 34(8):801-9. PubMed ID: 16910493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-operative hemorrhage due to hyperperfusion during direct revascularization surgery in an adult patient with moyamoya disease: a case report.
    Uchida H; Endo H; Fujimura M; Endo T; Niizuma K; Tominaga T
    Neurosurg Rev; 2017 Oct; 40(4):679-684. PubMed ID: 28600750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Seizure following superficial temporal-middle cerebral artery anastomosis in patients with moyamoya disease: possible contribution of postoperative cerebral hyperperfusion].
    Narisawa A; Fujimura M; Shimizu H; Tominaga T
    No Shinkei Geka; 2007 May; 35(5):467-74. PubMed ID: 17491342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal change of 3-T magnetic resonance imaging/angiography during symptomatic cerebral hyperperfusion following superficial temporal artery-middle cerebral artery anastomosis in a patient with adult-onset moyamoya disease.
    Kohama M; Fujimura M; Mugikura S; Tominaga T
    Neurosurg Rev; 2008 Oct; 31(4):451-5; discussion 455. PubMed ID: 18548300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of moyamoya disease presenting with progressive stroke during the late perinatal period successfully managed by bilateral revascularization surgeries].
    Sasaki T; Fujimura M; Akamatsu Y; Kimura N; Ezura M; Uenohara H; Akagi K; Tominaga T
    No Shinkei Geka; 2012 Dec; 40(12):1095-9. PubMed ID: 23180747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo ivy sign indicates postoperative hyperperfusion in moyamoya disease.
    Horie N; Morikawa M; Morofuji Y; Hiu T; Izumo T; Hayashi K; Nagata I
    Stroke; 2014 May; 45(5):1488-91. PubMed ID: 24713526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.
    Fujimura M; Mugikura S; Kaneta T; Shimizu H; Tominaga T
    Surg Neurol; 2009 Apr; 71(4):442-7. PubMed ID: 18514264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective surgical revascularization improves cerebral hemodynamics and resolves headache in pediatric Moyamoya disease.
    Kawabori M; Kuroda S; Nakayama N; Hirata K; Shiga T; Houkin K; Tamaki N
    World Neurosurg; 2013 Nov; 80(5):612-9. PubMed ID: 23022638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiopulmonary complication as a pitfall of the perioperative management of moyamoya syndrome with atherosclerosis: conflict to counteract with cerebral hyperperfusion].
    Sakata H; Fujimura M; Sato K; Shimizu H; Tominaga T
    No Shinkei Geka; 2014 Aug; 42(8):737-43. PubMed ID: 25087762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease.
    Fujimura M; Inoue T; Shimizu H; Saito A; Mugikura S; Tominaga T
    Cerebrovasc Dis; 2012; 33(5):436-45. PubMed ID: 22456617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uneven cerebral hemodynamic change as a cause of neurological deterioration in the acute stage after direct revascularization for moyamoya disease: cerebral hyperperfusion and remote ischemia caused by the 'watershed shift'.
    Tu XK; Fujimura M; Rashad S; Mugikura S; Sakata H; Niizuma K; Tominaga T
    Neurosurg Rev; 2017 Jul; 40(3):507-512. PubMed ID: 28357585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.